M Ventures Fund

The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck’s business areas, though formally separated by a “Chinese Wall”. The total volume of the corporate venture fund is € 300 million.

Healthcare

The Healthcare fund is the strategic, corporate venture arm of the biopharmaceutical division of Merck. We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.

Healthcare Team

more about
Hakan Goker
Managing Director
more about
Cheryl Zimberlin
Investment Director

Along with the Merck Healthcare commitment, our team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.

The M Ventures Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R&D center.

Companies

more about
Artios
more about
Asceneuron
more about
Calypso Biotech
more about
F-Star
more about
Forendo Therapeutics
more about
Galecto Biotech
more about
Inthera
more about
iOmx Therapeutics
more about
iOnctura
more about
Macrophage Pharma
more about
Metabomed LTD
more about
ObsEva
more about
Prexton Therapeutics
more about
Storm Therapeutics
more about
Synaffix BV
more about
RaNA Therapeutics now Translate Bio
more about
Vaximm

Life Science

The Life Science Team invests in areas of strategic value to the life science division of Merck.

Life Science Team

more about
Hakan Goker
Managing Director
more about
Cheryl Zimberlin
Investment Director

We invest globally in emerging life science companies that develop products, services and or technologies that have the potential to make research and biotech production easier, faster, more successful and enhance customer service. The Life Science team helps driving better solutions for our customers.

Companies

more about
DNA SCRIPT
more about
Indi molecular
more about
nanoSyrinx
more about
Pictor Labs
more about
Plexium
more about
SciPio Bioscience

Electronics

The Electronics Fund is the strategic, corporate venture arm of the performance materials division of Merck.

Electronics Team

more about
Javier Rodriguez
more about
Sebastian Schoefer
Investment Director
more about
Christian Patze
Investment Director
more about
Daniel Franke
Principal
more about
Sarah Luppino
Associate
more about
Robert Even
BD Manager Israel
more about
Owen Lozman
Managing Director
more about
Radhika Ramachandran

Discovering and unleashing the most innovative startups in the Electronics sector, the fund targets companies developing applications and solutions for the future of computing, data storage, display and device miniaturization.

Companies

more about
Alcan Systems
more about
aveni
more about
Celestial.AI
more about
Electroninks
more about
Ferroelectric Memory GmbH
more about
IKAS
more about
Lumiode
more about
MemryX
more about
Metalenz
more about
Neologic
more about
Peratech
more about
PxE
more about
SeeQC
more about
TIGNIS
more about
Stealth Company
more about
SynSense

Frontier Tech & Sustainability

The New Businesses Fund is the strategic, corporate venture arm of Merck.

Frontier Tech & Sustainability Team

more about
Javier Rodriguez
more about
Sebastian Schoefer
Investment Director
more about
Christian Patze
Investment Director
more about
Daniel Franke
Principal
more about
Sarah Luppino
Associate
more about
Robert Even
BD Manager Israel
more about
Owen Lozman
Managing Director
more about
Björn Kuhl
Head of Operations
more about
Radhika Ramachandran

This fund exists to pursue interdisciplinary approaches with opportunities that serve multiple business sectors or have a strong element of technology convergence. The Frontier Tech and Sustainability fund is looking for novel technologies, services and business models that can positively impact the sustainability of both Merck and our customers, be that via novel production of materials or through innovations in the application of digital technologies.

Companies

more about
Akili
more about
Altoida
more about
Biolinq
more about
Formo
more about
Medisafe
more about
micropsi industries
more about
mosa meat
more about
Neurable
more about
Pilltracker
more about
Sonde Health
more about
Wiliot